Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Aspen Aerogels (ASPN) over the last 13 years, with Q3 2025 value amounting to -$1.2 million.

  • Aspen Aerogels' Change in Account Payables rose 9118.82% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.8 million, marking a year-over-year decrease of 23581.17%. This contributed to the annual value of $7.3 million for FY2024, which is 6017.89% up from last year.
  • Latest data reveals that Aspen Aerogels reported Change in Account Payables of -$1.2 million as of Q3 2025, which was up 9118.82% from -$10.7 million recorded in Q2 2025.
  • Aspen Aerogels' Change in Account Payables' 5-year high stood at $15.4 million during Q2 2024, with a 5-year trough of -$15.5 million in Q3 2022.
  • Its 5-year average for Change in Account Payables is $467947.4, with a median of $2.1 million in 2024.
  • The largest annual percentage gain for Aspen Aerogels' Change in Account Payables in the last 5 years was 41055.34% (2022), contrasted with its biggest fall of 797239.58% (2022).
  • Quarter analysis of 5 years shows Aspen Aerogels' Change in Account Payables stood at $3.6 million in 2021, then soared by 34.03% to $4.8 million in 2022, then grew by 3.43% to $5.0 million in 2023, then tumbled by 42.25% to $2.9 million in 2024, then plummeted by 139.84% to -$1.2 million in 2025.
  • Its last three reported values are -$1.2 million in Q3 2025, -$10.7 million for Q2 2025, and -$3.9 million during Q1 2025.